Boston Sci chief stepping down; Hib vax no longer scarce, CDC says;

> Boston Scientific CEO James Tobin will leave the device maker, to be succeeded by Raymond Elliott, ex-chief of the orthopedic device firm Zimmer Holdings. Report

> The government declared an end to a shortage of a childhood vaccine that protects against Haemophilus influenza type B, a shot that had grown scarce after a 2007 Merck recall. Report

> Singapore's industrial production unexpectedly increased in May as pharmaceutical companies boosted output. Report

> European regulators recommended that a 50-year-old painkiller be withdrawn from the market out of concern that patients have been fatally overdosing. Report

> Novavax appointed Stanley Erck, who served most recently as president and CEO of vaccine developer Iomai, to the company's Board of Directors. Report

> UCB and Sepracor filed suit in U.S. District Court against Synthon Pharmaceuticals, alleging patent infringement related to its generic version of Xyzal solution. Report

Biotech News

> Lexington, MA-based start-up Taris Biomedical has snared $15 million in its Series A, which will be put to use advancing a new drug-device therapy for bladder disease. Taris had been flying under the radar prior to its emergence at a conference yesterday. Report

> An experimental cancer therapy that's one of a new class of PARP inhibitors produced some surprisingly positive results in a small study of cancer victims who share BRCA1 and BRCA2 genetic mutations. Report

> FDA officials heard an earful yesterday from consumer advocates who want to put drugs and data in a public spotlight--a prospect that makes many developers distinctly uncomfortable. Report

> It turns out that Sanofi-Aventis' plans to restructure its R&D operations may have as much to do with cutting costs as it does with boosting outside development alliances. Report

> Insmed's lead drug failed to show efficacy in a mid-stage clinical trial of a genetic condition called myotonic muscular dystrophy and investors swiftly hammered the stock, sending down shares more than 50 percent on the news. Report

And Finally... Swine flu has infected as many as 1 million Americans, with 6 percent or more of some urban populations infected. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.